Our platform is a way to study fat cells outside a human or animal body, or in vitro. Our stem-cell platform, M3, is unique in its accuracy in replicating human fat cells.
Dr. Peterson is an Assistant Professor of Physiology at the Mayo Clinic. His research focus is diabetes drug discovery through chemical screening.
His track record includes development of a novel class of drugs now in Phase I clinical trials. He advises MelliCell in high-throughput screening and lead development.
Copyright © 2024 MelliCell. All Rights Reserved.